文献速递神经肿瘤

非侵入性尸检验证的肿瘤概率图识别胶质瘤对比增强以外的侵袭

Noninvasive Autopsy-Validated Tumor Probability Maps Identify Glioma Invasion Beyond Contrast Enhancement.
PubMed 文献 · Neurosurgery · 2024-03-19

本研究回顾性对齐65例胶质瘤患者的159份尸检组织样本与死亡前最近的MRI,利用集成算法构建放射-病理学肿瘤概率图,发现41.5%的患者存在对比增强以外的肿瘤且生存更差(HR=3.90,P<.001),概率图在69%的术前病例中识别出对比增强外肿瘤并显示生存降低(HR=1.67,P=.027)。

要点

  • 41.5%的患者在对比增强范围外存在肿瘤,其生存结局更差(HR=3.90,P<.001)。
  • 肿瘤概率图在局部和外部未见数据上可靠追踪非增强肿瘤。
  • 概率图在69%的术前病例中识别出对比增强外肿瘤,且这些病例生存降低(HR=1.67,P=.027)。

核心结论

  • 本研究利用尸检组织样本作为金标准,开发了一种多阶段模型来绘制胶质瘤,能够识别传统影像特征以外的肿瘤区域。

研究设计与样本

  • 回顾性研究,共纳入65例受试者的159份组织样本,对齐死亡前最近的MRI。
  • 计算有和无对比增强边缘外肿瘤患者的人口学和生存特征。
  • 使用集成算法从病理注释预测像素级肿瘤存在,输入为分割的细胞密度、细胞外液和细胞质密度(6例训练/3例测试受试者)。
  • 第二级集成算法在全数据集(43例训练/22例测试受试者)上使用T1、T1+C、FLAIR和ADC的5×5体素块预测体素级细胞密度、细胞外液和细胞质。
  • 结合模型生成非侵入性全脑肿瘤概率图。

主要发现

  • 41.5%的患者在对比增强范围外存在肿瘤,其生存结局更差(HR=3.90,P<.001)。
  • 肿瘤概率图在局部和外部未见数据上可靠追踪非增强肿瘤。
  • 概率图在69%的术前病例中识别出对比增强外肿瘤,这些病例也显示生存结局降低(HR=1.67,P=.027)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: This study identified a clinically significant subset of patients with glioma with tumor outside of contrast enhancement present at autopsy and subsequently developed a method for detecting nonenhancing tumor using radio-pathomic mapping. We tested the hypothesis that autopsy-based radio-pathomic tumor probability maps would be able to noninvasively identify areas of infiltrative tumor beyond traditional imaging signatures. METHODS: A total of 159 tissue samples from 65 subjects were aligned to MRI acquired nearest to death for this retrospective study. Demographic and survival characteristics for patients with and without tumor beyond the contrast-enhancing margin were computed. An ensemble algorithm was used to predict pixelwise tumor presence from pathological annotations using segmented cellularity (Cell), extracellular fluid, and cytoplasm density as input (6 train/3 test subjects). A second level of ensemble algorithms was used to predict voxelwise Cell, extracellular fluid, and cytoplasm on the full data set (43 train/22 test subjects) using 5-by-5 voxel tiles from T1, T1 + C, fluid-attenuated inversion recovery, and apparent diffusion coefficient as input. The models were then combined to generate noninvasive whole brain maps of tumor probability. RESULTS: Tumor outside of contrast was identified in 41.5% of patients, who showed worse survival outcomes (hazard ratio = 3.90, P < .001). Tumor probability maps reliably tracked nonenhancing tumor on a range of local and external unseen data, identifying tumor outside of contrast in 69% of presurgical cases that also showed reduced survival outcomes (hazard ratio = 1.67, P = .027). CONCLUSION: This study developed a multistage model for mapping gliomas using autopsy tissue samples as ground truth, which was able to identify regions of tumor beyond traditional imaging signatures.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Bobholz SA, Lowman AK, Connelly JM, et al. Noninvasive Autopsy-Validated Tumor Probability Maps Identify Glioma Invasion Beyond Contrast Enhancement. Neurosurgery. 2024. PMID: 38501824. doi:10.1227/neu.0000000000002898

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。